Procter & Gamble Pharmaceuticals
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Procter & Gamble Pharmaceuticals - overview
Established
1837
Location
Cincinnati, OH, US
Primary Industry
Pharmaceuticals
About
Procter & Gamble Pharmaceuticals is a global entity specializing in consumer goods and personal care products aimed at enhancing everyday living through effective solutions in hygiene and cleanliness. Founded in 1837 and headquartered in Cincinnati, US, Procter & Gamble Pharmaceuticals focuses on developing consumer goods across various sectors. The company has undergone strategic shifts over its long history, including a significant acquisition by Warner Chilcott in 2009 for approximately USD 3. 1 bn.
The firm has engaged in one known deal, emphasizing its established market presence. Procter & Gamble Pharmaceuticals offers a diverse array of consumer goods, including household cleaning agents, personal hygiene items, and beauty products. These offerings are engineered to address consumer needs around cleanliness and grooming, targeting families and professionals. The company maintains a strong distribution network, selling its products across North America, Europe, and parts of Asia.
The company's revenue for the most recent fiscal year, 2009, was USD 2. 30 bn. The revenue generation strategy is supported through a multi-channel distribution approach, combining partnerships with major retailers and direct-to-consumer sales, which facilitates access to a wide audience. Procter & Gamble Pharmaceuticals aims to launch new products designed with advanced efficacy in mind, though specific release dates have not been disclosed.
The firm plans to expand its market presence in emerging regions, targeting new geographic areas. The recent acquisition deal in 2009 will likely facilitate resource allocation toward these growth initiatives.
Current Investors
Warner Chilcott
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.us.pg.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Procter & Gamble Pharmaceuticals - financials
| Fiscal Year Ended | Jan 01, 2009 |
|---|---|
| Revenue (USD) | - |
| % Revenue Growth (YoY) | - |
| EBITDA (USD) | - |
| Operating Income (USD) | - |
| Operating Margin | - |
| % EBITDA Margin | - |
| NET Income (USD) | - |
| % Net Margin | - |
Procter & Gamble Pharmaceuticals - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Zest Soap Brand | - | ||||||||
| Trade Sale | Completed | MDVIP, LLC | - | ||||||||
| Add-on | Completed | Procter & Gamble Pharmaceuticals | - | ||||||||
| Trade Sale | Completed | Frederic Fekkai & Co. | - |
Displaying 1 - 4 of 4

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.